Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan in perimenopausal hypertension
NCT04800081Unknown
- Sponsor
- Lanzhou University
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sacubitril + valsartan in hypertension (HTN), sponsored by Lanzhou University. Primary endpoint: Blood Pressure at 12 weeks. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04800081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800081.